ACR Convergence 2025 | Video: Rheuminations on Milestones & Ageism

Search results for: heart disease

Letters to the Editor

Staff | July 1, 2007

Feedback from our Readers

There Should Be No I in NSAID

David S. Pisetsky, MD, MPH | June 1, 2007

Medicine is a team activity—especially when it comes to clinical guidelines

Have We Reached an Estrogen Comfort Zone?

Jill P. Buyon, MD | May 1, 2007

A review of research on prescribing estrogens in systemic lupus erythematosus

Put Hughes Syndrome on Your Radar

Graham R.V. Hughes, MD | April 1, 2007

Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it

Medicare D-lemmas

Ann Kepler | January 1, 2007

Rheumatologists and patients report mixed experiences with the new prescription drug benefit

Labored Breathing

Staff | January 1, 2007

Strategies to diagnose and manage dyspnea in the scleroderma patient

Reading RHEUM

Robyn T. Domsic, MD; Kathleen A. Haines, MD; Daniel H. Solomon, MD, MPH; | November 1, 2006

Handpicked Reviews of Contemporary Literature

Promising Combination Treatment for Gout

Michele B. Kaufman, PharmD, BCGP | October 27, 2025

The FDA has accepted a biologics license application for nano-encapsulated sirolimus with pegylated-adricase (NASP), a combination treatment designed to reduce serum uric acid levels in patients with uncontrolled gout.

The ACR Names 16 New Masters

Patrice Fusillo | October 25, 2025

The ACR recognizes 16 members with its highest honor. See the 2025 class of ACR Masters & read their personal reflections on this career milestone.

A Liquid Biopsy for Lupus Nephritis?

Samantha C. Shapiro, MD | October 10, 2025

Urine biomarkers have the potential to change how lupus nephritis is managed, serving as a noninvasive means of early detection, assessing treatment response and more.